Literature DB >> 6393865

Hydroxylamine technique for in vitro prevention of penicillin inactivation of tobramycin.

A J Falkowski, R J Creger.   

Abstract

Hydroxylamine was evaluated and found to be a highly effective agent for the in vitro prevention of penicillin inactivation of tobramycin. This inactivation reaction resulted in an underestimation of tobramycin concentrations and was dependent on time, temperature, amount and type of penicillin, and amount of tobramycin. Plasma samples containing tobramycin and three clinically relevant concentrations of ticarcillin, carbenicillin, azlocillin, or piperacillin were incubated with and without hydroxylamine, and tobramycin concentrations were monitored at 0, 12, 24, 48, and 72 h. The inactivation reaction was found to be completely inhibited by hydroxylamine (1 mg/ml) compared with a 27 to 50% loss of measured tobramycin concentration in the unprotected tobramycin-penicillin samples. Hydroxylamine did not interfere with the Emit enzyme immunoassay (Syva Co.) at either high or low tobramycin concentrations. Hydroxylamine was effective in inhibiting the tobramycin inactivation at both room and refrigerator temperatures and was 100% effective in protecting tobramycin on a 1:1 molar basis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6393865      PMCID: PMC179985          DOI: 10.1128/AAC.26.5.643

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Synergy between aminoglycosides and semi-synthetic penicillins against gentamicin-resistant Gram-negative rods.

Authors:  W Farrell; M Wilks; F A Drasar
Journal:  J Antimicrob Chemother       Date:  1979-01       Impact factor: 5.790

2.  Clinical and laboratory evidence for inactivation of gentamicin by carbenicillin.

Authors:  J E McLaughlin; D S Reeves
Journal:  Lancet       Date:  1971-02-06       Impact factor: 79.321

3.  Therapeutic implications of interaction of gentamicin and penicillins.

Authors:  P Noone; J R Pattison
Journal:  Lancet       Date:  1971-09-11       Impact factor: 79.321

4.  Use of gentamicin in combinations with other antibiotics.

Authors:  C B Smith; P E Dans; J N Wilfert; M Finland
Journal:  J Infect Dis       Date:  1969 Apr-May       Impact factor: 5.226

5.  Laboratory and clinical conditions for gentamicin inactivation by carbenicillin.

Authors:  L J Riff; G G Jackson
Journal:  Arch Intern Med       Date:  1972-12

6.  Biological aspects of the interaction between gentamicin and carbenicillin.

Authors:  J A Waitz; C G Drube; E L Moss; E M Oden; J V Bailey
Journal:  J Antibiot (Tokyo)       Date:  1972-04       Impact factor: 2.649

7.  In-vitro inactivation of aminoglycoside antibiotics by piperacillin and carbenicillin.

Authors:  D C Hale; R Jenkins; J M Matsen
Journal:  Am J Clin Pathol       Date:  1980-09       Impact factor: 2.493

8.  Animal model distinguishing in vitro from in vivo carbenicillin-aminoglycoside interactions.

Authors:  J A Pieper; R A Vidal; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

9.  Effect of time and concentration upon interaction between gentamicin, tobramycin, Netilmicin, or amikacin and carbenicillin or ticarcillin.

Authors:  L K Pickering; P Gearhart
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191

10.  In vitro inactivation of gentamicin, tobramycin, and netilmicin by carbenicillin, azlocillin, or mezlocillin.

Authors:  J L Henderson; R E Polk; B J Kline
Journal:  Am J Hosp Pharm       Date:  1981-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.